{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:36:23Z","timestamp":1793421383859,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-024-00714-0","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T17:59:47Z","timestamp":1736359187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation between family function and self-management abilities in patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1186","volume":"44","author":[{"given":"Yueying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"6","key":"714_CR1","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","volume":"79","author":"AL Hutchison","year":"2023","unstructured":"Hutchison AL, Tavaglione F, Romeo S, Charlton M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J Hepatol. 2023;79(6):1524\u201341.","journal-title":"J Hepatol"},{"issue":"8","key":"714_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"714_CR3","first-page":"691","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"6","key":"714_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","volume":"22","author":"M Kalligeros","year":"2024","unstructured":"Kalligeros M, Vassilopoulos A, Vassilopoulos S, Victor DW, Mylonakis E, Noureddin M. Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017\u20132020. Clin Gastroenterol Hepatol. 2024;22(6):1330\u2013e13324.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"714_CR5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the Liver (EASL)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu; European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO); European Association for the study of the liver (EASL). EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","journal-title":"J Hepatol"},{"key":"714_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-publhealth-040218-044008","volume":"40","author":"JP Allegrante","year":"2019","unstructured":"Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of Chronic diseases. Annu Rev Public Health. 2019;40:127\u201346.","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"714_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/09638288.2022.2028019","volume":"45","author":"A Sahely","year":"2023","unstructured":"Sahely A, Giles D, Sintler C, Soundy A, Rosewilliam S. Self-management interventions to improve mobility after stroke: an integrative review. Disabil Rehabil. 2023;45(1):9\u201326.","journal-title":"Disabil Rehabil"},{"issue":"05","key":"714_CR8","first-page":"947","volume":"34","author":"Chinese Society of Hepatology, Liver Disease and Alcoholic Liver Disease Group","year":"2018","unstructured":"Chinese Society of Hepatology, Liver Disease and Alcoholic Liver Disease Group. Guidelines for the Prevention and Treatment of non-alcoholic fatty liver disease (2018). Clin J Hepatol. 2018;34(05):947\u201357.","journal-title":"Clin J Hepatol"},{"issue":"11","key":"714_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56(11):951\u201363.","journal-title":"J Gastroenterol"},{"key":"714_CR10","doi-asserted-by":"crossref","unstructured":"Ivancovsky Wajcman D, Byrne CJ, Dillon JF, Brennan PN, Villota-Rivas M, Younossi ZM, Allen AM, Crespo J, Gerber LH, Lazarus JV. A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease. Hepatology. 2024;15.","DOI":"10.1097\/HEP.0000000000001058"},{"key":"714_CR11","doi-asserted-by":"crossref","unstructured":"Koca SB, B\u00fck\u00fclmez A, Oflu AT, Tahta EG, Demirbilek H. Nutritional habits, compliance with healthy diet and insulin therapy, depression and family functionality in children with type 1 diabetes mellitus during the covid-19 pandemic period. Acta Endocrinol (Buchar). 2022;18(1):40\u20138.","DOI":"10.4183\/aeb.2022.40"},{"issue":"1","key":"714_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s41043-024-00618-z","volume":"43","author":"X Lin","year":"2024","unstructured":"Lin X, Bao S, Yu Y, Huang H, Shu M. Self-management in patients with metabolic dysfunction-associated steatotic liver disease: influencing factors and impact on readmission. J Health Popul Nutr. 2024;43(1):134.","journal-title":"J Health Popul Nutr"},{"issue":"4","key":"714_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/famp.12065","volume":"53","author":"R Archambault","year":"2014","unstructured":"Archambault R, Mansfield AK, Evans D, Keitner GI. Using the tenets of the problem-centered systems therapy of the family (PCSTF) to teach the McMaster Approach to family therapists. Fam Process. 2014;53(4):640\u201355.","journal-title":"Fam Process"},{"issue":"3","key":"714_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023;32(3):197\u2013213.","journal-title":"J Obes Metab Syndr"},{"issue":"3","key":"714_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","volume":"13","author":"F Abdelhameed","year":"2024","unstructured":"Abdelhameed F, Kite C, Lagojda L, Dallaway A, Chatha KK, Chaggar SS, Dalamaga M, Kassi E, Kyrou I, Randeva HS. Non-invasive scores and serum biomarkers for fatty liver in the era of metabolic dysfunction-associated Steatotic Liver Disease (MASLD): a Comprehensive Review from NAFLD to MAFLD and MASLD. Curr Obes Rep. 2024;13(3):510\u201331.","journal-title":"Curr Obes Rep"},{"key":"714_CR16","doi-asserted-by":"crossref","unstructured":"Riegel B, Lee S, Hill J, Daus M, Baah FO, Wald JW, Knafl GJ. Patterns of adherence to diuretics, dietary sodium and fluid intake recommendations in adults with heart failure. Heart Lung. 2019;48(3):179\u201385.","DOI":"10.1016\/j.hrtlng.2018.12.008"},{"issue":"8","key":"714_CR17","doi-asserted-by":"publisher","first-page":"e074739","DOI":"10.1136\/bmjopen-2023-074739","volume":"13","author":"X Wang","year":"2023","unstructured":"Wang X, Tang P, Li L, Jiang Y, Zhao Y, Tang L, Shao J, Chen DD. Exploring the relationship between self-management behaviour, family function and health information adoption behaviour in Chinese diabetic foot patients: a mixed-methods study protocol. BMJ Open. 2023;13(8):e074739.","journal-title":"BMJ Open"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-024-00714-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-024-00714-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-024-00714-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:04:24Z","timestamp":1736359464000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhpn.biomedcentral.com\/articles\/10.1186\/s41043-024-00714-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1186\/s41043-024-00714-0","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. Ethics Approval Number: KY2017-1-5.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that all authors have agreed to submit and publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}